The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

PubWeight™: 0.78^‹?›

🔗 View Article (PMID 26478889)

Published in J Prev Alzheimers Dis on December 01, 2014

Authors

E Cavedo¹, S Lista², Z Khachaturian³, P Aisen⁴, P Amouyel⁵, K Herholz⁶, C R Jack⁷, R Sperling⁸, J Cummings⁹, K Blennow¹⁰, S O'Bryant¹¹, G B Frisoni¹², A Khachaturian¹³, M Kivipelto¹⁴, W Klunk¹⁵, K Broich¹⁶, S Andrieu¹⁷, M Thiebaut de Schotten¹⁸, J-F Mangin¹⁹, A A Lammertsma²⁰, K Johnson²¹, S Teipel²², A Drzezga²³, A Bokde²⁴, O Colliot²⁵, H Bakardjian²⁶, H Zetterberg²⁷, B Dubois²⁸, B Vellas²⁹, L S Schneider³⁰, H Hampel²

Author Affiliations

1: Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Institut du Cerveau et de la Moelle épinière (ICM), UMR S 1127, Hôpital de la Pitié-Salpétrière Paris & CATI multicenter neuroimaging platform, France; Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio Fatebenefratelli Brescia, Italy.
2: AXA Research Fund & UPMC Chair; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Inserm U1127 Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière Paris, France.
3: The Campaign to Prevent Alzheimer's Disease by 2020 (PAD2020), Potomac, MD, USA.
4: Department of Neurosciences, University of California San Diego, San Diego, CA, USA.
5: Inserm, U744, Lille, 59000, France; Université Lille 2, Lille, 59000, France; Institut Pasteur de Lille, Lille, 59000, France; Centre Hospitalier Régional Universitaire de Lille, Lille, 59000, France.
6: Institute of Brain, Behaviour and Mental Health, University of Manchester, UK.
7: Department of Radiology, Mayo Clinic, Rochester, MN, USA.
8: Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
9: Cleveland Clinic Lou Ruvo Center for Brain Health, 888 West Bonneville Avenue, Las Vegas, Nevada 89106, USA.
10: Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
11: Department of Internal Medicine, Institute for Aging & Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, TX, USA.
12: IRCCS Istituto Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; University Hospitals and University of Geneva, Geneva, Switzerland.
13: Executive Editor, Alzheimer's & Dementia.
14: Karolinska Institutet Alzheimer Research Center, NVS, Stockholm, Sweden.
15: Department of Psychiatry, University of Pittsburgh School of Medicine, USA; Department of Neurology, University of Pittsburgh School of Medicine, USA.
16: Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany.
17: Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France; Public health department, CHU de Toulouse.
18: Natbrainlab, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, King's College London, London, UK; Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (ICM), UMRS 1127 Paris, France; Inserm, U 1127, Paris, France; CNRS, UMR 7225, Paris, France.
19: CEA UNATI, Neurospin, CEA Gif-sur-Yvette, France & CATI multicenter neuroimaging platform.
20: Department of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
21: Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
22: Department of Psychosomatic Medicine, University of Rostock, and DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany.
23: Department of Nuclear Medicine, University Hospital of Cologne, Cologne Germany.
24: Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
25: Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, Inserm, U1127, F-75013, Paris, France; CNRS, UMR 7225 ICM, 75013, Paris, France; Inria, Aramis project-team, Centre de Recherche Paris-Rocquencourt, France.
26: Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpétrière University Hospital, Paris, France; IHU-A-ICM - Paris Institute of Translational Neurosciences, Paris, France.
27: Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, UK.
28: Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Hôpital de la Pitié-Salpétrière & Inserm U1127 Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière Paris, France.
29: Inserm UMR1027, University of Toulouse, Toulouse, France.
30: Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26478889)

Authors

Author Affiliations

Associated clinical trials:

Articles citing this ↘

Articles cited by this ↗

(truncated to the top 100)

Articles by these authors ⇆

PubWeight™: 0.78^‹?›